Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer
Abstract
:Simple Summary
Abstract
1. Introduction
2. The Principles of Magnetic Resonance Fingerprinting
3. Magnetic Resonance Fingerprinting for Imaging Cancer
3.1. Brain Tumours
3.2. Prostate Cancer
3.3. Lesions in Abdomen and Pelvis—Liver and Ovaries
4. Potential Future Developments for Cancer Management
4.1. Inter- and Intra-Tumoral Heterogeneity
4.2. Response Monitoring
5. Current Limitations of MR Fingerprinting
5.1. Motion Robustness
5.2. Acquisition and Processing Time
5.3. Adoption of MR Fingerprinting by the Imaging and Oncology Community
6. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Villanueva-Meyer, J.E.; Mabray, M.; Cha, S. Current Clinical Brain Tumor Imaging. Neurosurgery 2017, 81, 397–415. [Google Scholar] [CrossRef] [PubMed]
- Bago-Horvath, Z.; Bernard-Davila, B.; Helbich, T.H.; Zhang, M.; Morris, E.A.; Thakur, S.B.; Albíztegui, R.E.O.; Leithner, D.; Marino, M.A.; Baltzer, P.A.; et al. Diffusion—Weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer. J. Magn. Reson. Imaging 2019, 50, 836–846. [Google Scholar] [CrossRef] [PubMed]
- Ravoori, M.K.; Nishimura, M.; Singh, S.P.; Lu, C.; Han, L.; Hobbs, B.P.; Pradeep, S.; Choi, H.J.; Bankson, J.A.; Sood, A.K.; et al. Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS ONE 2015, 10, e0131095. [Google Scholar] [CrossRef]
- Weidensteiner, C.; Allegrini, P.R.; Sticker-Jantscheff, M.; Romanet, V.; Ferretti, S.; McSheehy, P.M. Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells—A preclinical MR study in mice. BMC Cancer 2014, 14, 88. [Google Scholar] [CrossRef] [PubMed]
- Adams, L.C.; Ralla, B.; Jurmeister, P.; Bressem, K.K.; Fahlenkamp, U.L.; Hamm, B.; Busch, J.; Makowski, M.R. Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation with histopathological findings. Investig. Radiol. 2019, 54, 118–128. [Google Scholar] [CrossRef] [PubMed]
- Hoskin, P.J.; Carnell, D.M.; Taylor, N.J.; Smith, R.E.; Stirling, J.J.; Daley, F.M.; Saunders, M.I.; Bentzen, S.M.; Collins, D.J.; D’Arcy, J.A.; et al. Hypoxia in Prostate Cancer: Correlation of BOLD-MRI With Pimonidazole Immunohistochemistry—Initial Observations. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68, 1065–1071. [Google Scholar] [CrossRef] [PubMed]
- Montelius, M.; Jalnefjord, O.; Spetz, J.; Nilsson, O.; Forssell-Aronsson, E.; Ljungberg, M. Multiparametric MR for non-invasive evaluation of tumour tissue histological characteristics after radionuclide therapy. NMR Biomed. 2019, 32, e4060. [Google Scholar] [CrossRef] [PubMed]
- Pykett, I.L.; Rosen, B.R.; Buonanno, F.S.; Brady, T.J. Measurement of spin-lattice relaxation times in nuclear magnetic resonance imaging. Phys. Med. Biol. 1983, 28, 723–729. [Google Scholar] [CrossRef]
- Meiboom, S.; Gill, D.R. Modified Spin—Echo Method for Measuring Nuclear Relaxation Times. Rev. Sci. Instrum. 1958, 29, 688–691. [Google Scholar] [CrossRef]
- Carr, H.Y.; Purcell, E.M. Effects of Diffusion on Free Precession in Nuclear Magnetic Resonance Experiments. Phys. Rev. 1954, 94, 630–638. [Google Scholar] [CrossRef]
- Messroghli, D.R.; Radjenovic, A.; Kozerke, S.; Higgins, D.M.; Sivananthan, M.U.; Ridgway, J.P. Modified Look-Locker inversion recovery (MOLLI) for high-resolutionT1 mapping of the heart. Magn. Reson. Med. 2004, 52, 141–146. [Google Scholar] [CrossRef] [PubMed]
- Deoni, S.C.L.; Peters, T.M.; Rutt, B.K. High-resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2. Magn. Reson. Med. 2005, 53, 237–241. [Google Scholar] [CrossRef] [PubMed]
- Schmitt, P.; Griswold, M.A.; Jakob, P.; Kotas, M.; Gulani, V.; Flentje, M.; Haase, A. Inversion recovery TrueFISP: Quantification of T1, T2, and spin density. Magn. Reson. Med. 2004, 51, 661–667. [Google Scholar] [CrossRef] [PubMed]
- Cheng, C.-C.; Preiswerk, F.; Hoge, W.S.; Kuo, T.-H.; Madore, B. Multipathway multi-Echo (MPME) imaging: All main MR parameters mapped based on a single 3D scan. Magn. Reson. Med. 2019, 81, 1699–1713. [Google Scholar] [CrossRef] [PubMed]
- Miraux, S.; Massot, P.; Ribot, E.J.; Franconi, J.-M.; Thiaudière, E. 3D TrueFISP imaging of mouse brain at 4.7T and 9.4T. J. Magn. Reson. Imaging 2008, 28, 497–503. [Google Scholar] [CrossRef]
- Ma, S.; Wang, N.; Fan, Z.; Kaisey, M.; Sicotte, N.L.; Christodoulou, A.G.; Li, D. Three-dimensional whole-brain simultaneous T1, T2, and T1 ρ quantification using MR Multitasking: Method and initial clinical experience in tissue characterization of multiple sclerosis. Magn. Reson. Med. 2021, 85, 1938–1952. [Google Scholar] [CrossRef] [PubMed]
- Ma, D.; Gulani, V.; Seiberlich, N.; Liu, K.; Sunshine, J.L.; Duerk, J.L.; Griswold, M.A. Magnetic resonance fingerprinting. Nat. Cell Biol. 2013, 495, 187–192. [Google Scholar] [CrossRef] [PubMed]
- Mehta, B.B.; Coppo, S.; McGivney, D.F.; Hamilton, J.I.; Chen, Y.; Jiang, Y.; Ma, D.; Seiberlich, N.; Gulani, V.; Griswold, M.A. Magnetic resonance fingerprinting: A technical review. Magn. Reson. Med. 2019, 81, 25–46. [Google Scholar] [CrossRef] [PubMed]
- McGivney, D.F.; Boyacıoğlu, R.; Jiang, Y.; Poorman, M.E.; Seiberlich, N.; Gulani, V.; Keenan, K.E.; Griswold, M.A.; Ma, D. Magnetic resonance fingerprinting review part 2: Technique and directions. J. Magn. Reson. Imaging 2020, 51, 993–1007. [Google Scholar] [CrossRef] [PubMed]
- Hsieh, J.J.L.; Svalbe, I. Magnetic resonance fingerprinting: From evolution to clinical applications. J. Med Radiat. Sci. 2020, 67, 333–344. [Google Scholar] [CrossRef]
- Cruz, G.; Jaubert, O.; Botnar, R.M.; Prieto, C. Cardiac Magnetic Resonance Fingerprinting: Technical Developments and Initial Clinical Validation. Curr. Cardiol. Rep. 2019, 21, 91. [Google Scholar] [CrossRef]
- Liu, Y.; Hamilton, J.; Rajagopalan, S.; Seiberlich, N. Cardiac Magnetic Resonance Fingerprinting: Technical Overview and Initial Results. JACC Cardiovasc. Imaging 2018, 11, 1837–1853. [Google Scholar] [CrossRef]
- Eck, B.L.; Flamm, S.D.; Kwon, D.H.; Tang, W.W.; Vasquez, C.P.; Seiberlich, N. Cardiac magnetic resonance fingerprinting: Trends in technical development and potential clinical applications. Prog. Nucl. Magn. Reson. Spectrosc. 2021, 122, 11–22. [Google Scholar] [CrossRef]
- Poorman, M.E.; Martin, M.N.; Ma, D.; McGivney, D.F.; Gulani, V.; Griswold, M.A.; Keenan, K.E. Magnetic resonance fingerprinting Part 1: Potential uses, current challenges, and recommendations. J. Magn. Reson. Imaging 2020, 51, 675–692. [Google Scholar] [CrossRef]
- Panda, A.; Mehta, B.B.; Coppo, S.; Jiang, Y.; Ma, D.; Seiberlich, N.; Griswold, M.A.; Gulani, V. Magnetic resonance fingerprinting—An overview. Curr. Opin. Biomed. Eng. 2017, 3, 56–66. [Google Scholar] [CrossRef] [PubMed]
- Weigel, M. Extended phase graphs: Dephasing, RF pulses, and echoes—Pure and simple. J. Magn. Reson. Imaging 2015, 41, 266–295. [Google Scholar] [CrossRef] [PubMed]
- Doneva, M.; Amthor, T.; Koken, P.; Sommer, K.; Börnert, P. Matrix completion-based reconstruction for undersampled magnetic resonance fingerprinting data. Magn. Reson. Imaging 2017, 41, 41–52. [Google Scholar] [CrossRef] [PubMed]
- McGivney, D.F.; Pierre, E.; Ma, D.; Jiang, Y.; Saybasili, H.; Gulani, V.; Griswold, M.A. SVD Compression for Magnetic Resonance Fingerprinting in the Time Domain. IEEE Trans. Med. Imaging 2014, 33, 2311–2322. [Google Scholar] [CrossRef] [PubMed]
- Cruz, G.; Jaubert, O.; Qi, H.; Bustin, A.; Milotta, G.; Schneider, T.; Koken, P.; Doneva, M.; Botnar, R.M.; Prieto, C. 3D free-breathing cardiac magnetic resonance fingerprinting. NMR Biomed. 2020, 33, 4370. [Google Scholar] [CrossRef]
- Da Cruz, G.L.; Bustin, A.; Jaubert, O.; Schneider, T.; Botnar, R.M.; Prieto, C. Sparsity and locally low rank regularization for MR fingerprinting. Magn. Reson. Med. 2019, 81, 3530–3543. [Google Scholar] [CrossRef]
- Nayak, L.; Lee, E.Q.; Wen, P.Y. Epidemiology of Brain Metastases. Curr. Oncol. Rep. 2012, 14, 48–54. [Google Scholar] [CrossRef]
- Giese, A.; Bjerkvig, R.; Berens, M.; Westphal, M. Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment. J. Clin. Oncol. 2003, 21, 1624–1636. [Google Scholar] [CrossRef]
- Cha, S. Neuroimaging in neuro-oncology. Neurotherapeutics 2009, 6, 465–477. [Google Scholar] [CrossRef]
- Kamson, D.O.; Mittal, S.; Buth, A.; Muzik, O.; Kupsky, W.J.; Robinette, N.L.; Barger, G.R.; Juhász, C. Differentiation of Glioblastomas from Metastatic Brain Tumors by Tryptophan Uptake and Kinetic Analysis: A Positron Emission Tomographic Study with Magnetic Resonance Imaging Comparison. Mol. Imaging 2013, 12, 327–337. [Google Scholar] [CrossRef]
- Cha, S.; Lupo, J.; Chen, M.-H.; Lamborn, K.; McDermott, M.; Berger, M.; Nelson, S.; Dillon, W. Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging. Am. J. Neuroradiol. 2007, 28, 1078–1084. [Google Scholar] [CrossRef]
- Fatouros, P.P.; Marmarou, A. Use of magnetic resonance imaging for in vivo measurements of water content in human brain: Method and normal values. J. Neurosurg. 1999, 90, 109–115. [Google Scholar] [CrossRef] [PubMed]
- Schwarcz, A.; Berente, Z.; Osz, E.; Dóczi, T. Fast in Vivo Water Quantification in Rat Brain Oedema Based on T(1) Measurement at High Magnetic Field. Acta Neurochir. 2002, 144, 811–816. [Google Scholar] [CrossRef] [PubMed]
- Hattingen, E.; Jurcoane, A.; Daneshvar, K.; Pilatus, U.; Mittelbronn, M.; Steinbach, J.P.; Bähr, O. Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. Neuro-Oncology 2013, 15, 1395–1404. [Google Scholar] [CrossRef] [PubMed]
- Kern, M.; Auer, T.A.; Picht, T.; Misch, M.; Wiener, E. T2 mapping of molecular subtypes of WHO grade II/III gliomas. BMC Neurol. 2020, 20, 8–9. [Google Scholar] [CrossRef] [PubMed]
- Badve, C.; Yu, A.; Dastmalchian, S.; Rogers, M.; Ma, D.; Jiang, Y.; Margevicius, S.; Pahwa, S.; Lu, Z.; Schluchter, M.; et al. MR Fingerprinting of Adult Brain Tumors: Initial Experience. Am. J. Neuroradiol. 2017, 38, 492–499. [Google Scholar] [CrossRef] [PubMed]
- Dastmalchian, S.; Kilinc, O.; Onyewadume, L.; Tippareddy, C.; McGivney, D.; Ma, D.; Griswold, M.; Sunshine, J.; Gulani, V.; Barnholtz-Sloan, J.S.; et al. Radiomic analysis of magnetic resonance fingerprinting in adult brain tumors. Eur. J. Nucl. Med. Mol. Imaging 2021, 48, 683–693. [Google Scholar] [CrossRef] [PubMed]
- De Blank, P.; Badve, C.; Gold, D.R.; Stearns, D.; Sunshine, J.; Dastmalchian, S.; Tomei, K.; Sloan, A.E.; Barnholtz-Sloan, J.S.; Lane, A.; et al. Magnetic Resonance Fingerprinting to Characterize Childhood and Young Adult Brain Tumors. Pediatr. Neurosurg. 2019, 54, 310–318. [Google Scholar] [CrossRef] [PubMed]
- Zhang, R.; Shen, Y.; Bai, Y.; Zhang, X.; Wei, W.; Lin, R.; Feng, Q.; Wang, M.; Zhang, M.; Nittka, M.; et al. Application of magnetic resonance fingerprinting to differentiate grade I transitional and fibrous meningiomas from meningothelial meningiomas. Quant. Imaging Med. Surg. 2021, 11, 1447–1457. [Google Scholar] [CrossRef] [PubMed]
- Buonincontri, G.; Biagi, L.; Retico, A.; Cecchi, P.; Cosottini, M.; Gallagher, F.A.; Gómez, P.A.; Graves, M.; McLean, M.A.; Riemer, F.; et al. Multi-site repeatability and reproducibility of MR fingerprinting of the healthy brain at 1.5 and 3.0 T. NeuroImage 2019, 195, 362–372. [Google Scholar] [CrossRef] [PubMed]
- Schmidt, M.A.; Payne, G.S. Radiotherapy planning using MRI. Phys. Med. Biol. 2015, 60, R323–R361. [Google Scholar] [CrossRef]
- Herzog, R.; Elgort, D.R.; Flanders, A.E.; Moley, P.J. Variability in diagnostic error rates of 10 MRI centers performing lumbar spine MRI examinations on the same patient within a 3-week period. Spine J. 2017, 17, 554–561. [Google Scholar] [CrossRef]
- Schmeel, F.C. Variability in quantitative diffusion-weighted MR imaging (DWI) across different scanners and imaging sites: Is there a potential consensus that can help reducing the limits of expected bias? Eur. Radiol. 2018, 29, 2243–2245. [Google Scholar] [CrossRef]
- Lu, L.; Chen, Y.; Shen, C.; Lian, J.; Das, S.; Marks, L.; Lin, W.; Zhu, T. Initial assessment of 3D magnetic resonance fingerprinting (MRF) towards quantitative brain imaging for radiation therapy. Med. Phys. 2020, 47, 1199–1214. [Google Scholar] [CrossRef]
- Zhou, Z.; Han, P.; Zhou, B.; Christodoulou, A.G.; Shaw, J.L.; Deng, Z.; Li, D. Chemical exchange saturation transfer fingerprinting for exchange rate quantification. Magn. Reson. Med. 2018, 80, 1352–1363. [Google Scholar] [CrossRef]
- Cohen, O.; Huang, S.; McMahon, M.T.; Rosen, M.; Farrar, C.T. Rapid and quantitative chemical exchange saturation transfer (CEST) imaging with magnetic resonance fingerprinting (MRF). Magn. Reson. Med. 2018, 80, 2449–2463. [Google Scholar] [CrossRef]
- Heo, H.-Y.; Han, Z.; Jiang, S.; Schär, M.; van Zijl, P.C.; Zhou, J. Quantifying amide proton exchange rate and concentration in chemical exchange saturation transfer imaging of the human brain. NeuroImage 2019, 189, 202–213. [Google Scholar] [CrossRef]
- Mehrabian, H.; Desmond, K.L.; Soliman, H.; Sahgal, A.; Stanisz, G. Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation Transfer. Clin. Cancer Res. 2017, 23, 3667–3675. [Google Scholar] [CrossRef] [PubMed]
- Sagiyama, K.; Mashimo, T.; Togao, O.; Vemireddy, V.; Hatanpaa, K.J.; Maher, E.A.; Mickey, B.E.; Pan, E.; Sherry, D.; Bachoo, R.M.; et al. In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proc. Natl. Acad. Sci. USA 2014, 111, 4542–4547. [Google Scholar] [CrossRef] [PubMed]
- Yu, Y.; Lee, D.; Peng, S.; Zhang, K.; Zhang, Y.; Jiang, S.; Zhao, X.; Heo, H.; Wang, X.; Chen, M.; et al. Assessment of Glioma Response to Radiotherapy Using Multiple MRI Biomarkers with Manual and Semiautomated Segmentation Algorithms. J. Neuroimaging 2016, 26, 626–634. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Fang, Z.; Hung, S.-C.; Chang, W.-T.; Shen, D.; Lin, W. High-resolution 3D MR Fingerprinting using parallel imaging and deep learning. NeuroImage 2020, 206, 116329. [Google Scholar] [CrossRef] [PubMed]
- Lemasson, B.; Pannetier, N.; Coquery, N.; Boisserand, L.S.B.; Collomb, N.; Schuff, N.; Moseley, M.; Zaharchuk, G.; Barbier, E.L.; Christen, T. MR Vascular Fingerprinting in Stroke and Brain Tumors Models. Sci. Rep. 2016, 6, 37071. [Google Scholar] [CrossRef] [PubMed]
- Haubold, J.; Demircioglu, A.; Gratz, M.; Glas, M.; Wrede, K.; Sure, U.; Antoch, G.; Keyvani, K.; Nittka, M.; Kannengiesser, S.; et al. Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting. Eur. J. Nucl. Med. Mol. Imaging 2019, 47, 1435–1445. [Google Scholar] [CrossRef]
- Shin, T.; Smyth, T.B.; Ukimura, O.; Ahmadi, N.; Abreu, A.L.D.C.; Ohe, C.; Oishi, M.; Mimata, H.; Gill, I.S. Diagnostic accuracy of a five-point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image-fusion targeted biopsy of the prostate. BJU Int. 2017, 121, 77–83. [Google Scholar] [CrossRef] [PubMed]
- Rosenkrantz, A.B.; Lim, R.P.; Haghighi, M.; Somberg, M.B.; Babb, J.S.; Taneja, S.S. Comparison of Interreader Reproducibility of the Prostate Imaging Reporting and Data System and Likert Scales for Evaluation of Multiparametric Prostate MRI. Am. J. Roentgenol. 2013, 201, W612–W618. [Google Scholar] [CrossRef]
- Baur, A.D.J.; Hansen, C.M.; Rogasch, J.; Posch, H.; Elezkurtaj, S.; Maxeiner, A.; Erb-Eigner, K.; Makowski, M.R. Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence. Sci. Rep. 2020, 10, 3121. [Google Scholar] [CrossRef] [PubMed]
- Lee, C.H.; Hung, L.C. Quantitative T2-mapping using MRI for detection of prostate malignancy: A systematic review of the literature. Acta Radiol. 2019, 60, 1181–1189. [Google Scholar] [CrossRef]
- Yu, A.C.; Badve, C.; Ponsky, L.E.; Pahwa, S.; Dastmalchian, S.; Rogers, M.; Jiang, Y.; Margevicius, S.; Schluchter, M.; Tabayoyong, W.; et al. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer. Radiology 2017, 283, 729–738. [Google Scholar] [CrossRef]
- Panda, A.; O’Connor, G.; Lo, W.C.; Jiang, Y.; Margevicius, S.; Schluchter, M.; Ponsky, L.E.; Gulani, V. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping. Investig. Radiol. 2019, 54, 485–493. [Google Scholar] [CrossRef]
- Panda, A.; Obmann, V.C.; Lo, W.-C.; Margevicius, S.; Jiang, Y.; Schluchter, M.; Patel, I.J.; Nakamoto, D.; Badve, C.; Griswold, M.A.; et al. MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland. Radiology 2019, 292, 685–694. [Google Scholar] [CrossRef]
- Han, D.; Choi, M.H.; Lee, Y.J.; Kim, D.-H. Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies. Korean J. Radiol. 2021, 22, 1332–1340. [Google Scholar] [CrossRef]
- Sushentsev, N.; Kaggie, J.D.; Slough, R.A.; Carmo, B.; Barrett, T. Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study. PLoS ONE 2021, 16, e0245970. [Google Scholar] [CrossRef] [PubMed]
- Jiang, Y.; Hamilton, J.I.; Lo, W.C.; Wright, K.L.; Ma, D.; Coristine, A.J.; Seiberlich, N.; Gulani, V.; Griswold, M.A. Simultaneous T1, T2 and Diffusion Quantification Using Multiple Contrast Prepared Magnetic Resonance Fingerprinting. 2017. Available online: https://cds.ismrm.org/protected/17MProceedings/PDFfiles/1171.html (accessed on 16 August 2021).
- Chen, Y.; Jiang, Y.; Pahwa, S.; Ma, D.; Lu, L.; Twieg, M.D.; Wright, K.L.; Seiberlich, N.; Griswold, M.A.; Gulani, V. MR Fingerprinting for Rapid Quantitative Abdominal Imaging. Radiology 2016, 279, 278–286. [Google Scholar] [CrossRef] [PubMed]
- Raza, S.A.; Funicelli, L.; Sohaib, S.; Collins, D.; Scurr, E.; Leach, M.; Koh, D.-M. Assessment of colorectal hepatic metastases by quantitative T2 relaxation time. Eur. J. Radiol. 2012, 81, e536–e540. [Google Scholar] [CrossRef] [PubMed]
- A Goldberg, M.; Hahn, P.F.; Saini, S.; Cohen, M.S.; Reimer, P.; Brady, T.J.; Mueller, P.R. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. Am. J. Roentgenol. 1993, 160, 1011–1017. [Google Scholar] [CrossRef] [PubMed]
- Ye, H.; Ma, D.; Jiang, Y.; Cauley, S.F.; Du, Y.; Wald, L.; Griswold, M.A.; Setsompop, K. Accelerating magnetic resonance fingerprinting (MRF) using t-blipped simultaneous multislice (SMS) acquisition. Magn. Reson. Med. 2016, 75, 2078–2085. [Google Scholar] [CrossRef] [PubMed]
- Bs, S.S.H.; Boyacioglu, R.; Bolding, R.; BS, C.M.; Chen, Y.; Griswold, M.A. Free-Breathing Abdominal Magnetic Resonance Fingerprinting Using a Pilot Tone Navigator. J. Magn. Reson. Imaging 2021, 54, 1138–1151. [Google Scholar] [CrossRef]
- Kaggie, J.D.; Graves, M.J.; Gallagher, F.A.; Deen, S.; Kessler, D.A.; McLean, M.A.; Buonincontri, G.; Schulte, R.F.; Addley, H.; Sala, E.; et al. Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T1 and T2 Mapping in a PET/MR Setting. IEEE Trans. Radiat. Plasma Med. Sci. 2019, 3, 509–515. [Google Scholar] [CrossRef] [PubMed]
- Barth, M.M.; Smith, M.P.; Pedrosa, I.; Lenkinski, R.E.; Rofsky, N.M. Body MR Imaging at 3.0 T: Understanding the Opportunities and Challenges. Radiographics 2007, 27, 1445–1462. [Google Scholar] [CrossRef] [PubMed]
- Graves, M.J.; Mitchell, D.G. Body MRI artifacts in clinical practice: A physicist’s and radiologist’s perspective. J. Magn. Reson. Imaging 2013, 38, 269–287. [Google Scholar] [CrossRef] [PubMed]
- Schwarz, R.; Ng, C.K.Y.; Cooke, S.L.; Newmann, S.; Temple, J.; Piskorz, A.M.; Gale, D.; Sayal, K.; Murtaza, M.; Baldwin, P.J.; et al. Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis. PLoS Med. 2015, 12, e1001789. [Google Scholar] [CrossRef]
- Li, T.; Cui, D.; Hui, E.S.; Cai, J. Time-resolved magnetic resonance fingerprinting for radiotherapy motion management. Med. Phys. 2020, 47, 6286–6293. [Google Scholar] [CrossRef]
- Early Detection Innovation Projects—Pancreatic Cancer UK. Available online: https://www.pancreaticcancer.org.uk/research-projects/early-detection-innovation-projects/ (accessed on 9 July 2021).
- Goldenberg, J.M.; Pagel, M.D. Assessments of tumor metabolism with CEST MRI. NMR Biomed. 2019, 32, e3943. [Google Scholar] [CrossRef]
- Wu, B.; Warnock, G.; Zaiss, M.; Lin, C.; Chen, M.; Zhou, Z.; Mu, L.; Nanz, D.; Tuura, R.; Delso, G. An overview of CEST MRI for non-MR physicists. EJNMMI Phys. 2016, 3, 19. [Google Scholar] [CrossRef]
- Pujara, A.C.; Kim, E.; Axelrod, D.; Melsaether, A.N. PET/MRI in Breast Cancer. J. Magn. Reson. Imaging 2019, 49, 328–342. [Google Scholar] [CrossRef]
- Szyszko, T.; Cook, G. PET/CT and PET/MRI in head and neck malignancy. Clin. Radiol. 2018, 73, 60–69. [Google Scholar] [CrossRef]
- Iima, M.; Honda, M.; Sigmund, E.; Kishimoto, A.O.; Kataoka, M.; Togashi, K. Diffusion MRI of the breast: Current status and future directions. J. Magn. Reson. Imaging 2020, 52, 70–90. [Google Scholar] [CrossRef]
- Manetta, R.; Palumbo, P.; Gianneramo, C.; Bruno, F.; Arrigoni, F.; Natella, R.; Maggialetti, N.; Agostini, A.; Giovagnoni, A.; Di Cesare, E.; et al. Correlation between ADC values and Gleason score in evaluation of prostate cancer: Multicentre experience and review of the literature. Gland Surg. 2019, 8, S216–S222. [Google Scholar] [CrossRef]
- Chung, W.J.; Chung, H.W.; Shin, M.J.; Lee, S.H.; Lee, M.H.; Lee, J.S.; Kim, M.-J.; Lee, W.K. MRI to differentiate benign from malignant soft-tissue tumours of the extremities: A simplified systematic imaging approach using depth, size and heterogeneity of signal intensity. Br. J. Radiol. 2012, 85, e831–e836. [Google Scholar] [CrossRef] [PubMed]
- Burrell, R.A.; McGranahan, N.; Bartek, J.; Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nat. Cell Biol. 2013, 501, 338–345. [Google Scholar] [CrossRef] [PubMed]
- McGranahan, N.; Swanton, C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 2017, 168, 613–628. [Google Scholar] [CrossRef] [PubMed]
- Thampanitchawong, P. Liver biopsy: Complications and risk factors. World J. Gastroenterol. 2000, 5, 301–304. [Google Scholar] [CrossRef]
- Charalampoudis, P.; Markopoulos, C.; Kovacs, T. Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data. Eur. J. Surg. Oncol. 2018, 44, 5–14. [Google Scholar] [CrossRef]
- Dagogo-Jack, I.; Shaw, A.T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 2018, 15, 81–94. [Google Scholar] [CrossRef] [PubMed]
- Jackson, A.; O’Connor, J.; Parker, G.; Jayson, G. Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Clin. Cancer Res. 2007, 13, 3449–3459. [Google Scholar] [CrossRef] [PubMed]
- Padhani, A.; Liu, G.; Mu-Koh, D.; Chenevert, T.L.; Thoeny, H.C.; Takahara, T.; Dzik-Jurasz, A.; Ross, B.D.; Van Cauteren, M.; Collins, D.; et al. Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations. Neoplasia 2009, 11, 102–125. [Google Scholar] [CrossRef] [PubMed]
- Scattoni, V.; Russo, A.; Di Trapani, E.; Capitanio, U.; La Croce, G.; Montorsi, F. Repeated biopsy in the detection of prostate cancer: When and how many cores. Archivio Italiano Di Urologia E Andrologia 2014, 86, 311–313. [Google Scholar] [CrossRef]
- Ahmed, H.U.; Bosaily, A.E.-S.; Brown, L.C.; Gabe, R.; Kaplan, R.S.; Parmar, M.K.; PROMIS Study Group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study. Lancet 2017, 389, 815–822. [Google Scholar] [CrossRef]
- Eisenhauer, E.A.; Therasse, P.; Bogaerts, J.; Schwartz, L.; Sargent, D.; Ford, R.; Dancey, J.; Arbuck, S.; Gwyther, S.; Mooney, M.; et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer 2009, 45, 228–247. [Google Scholar] [CrossRef] [PubMed]
- Reig, B.; Heacock, L.; Lewin, A.; Cho, N.; Moy, L. Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer. J. Magn. Reson. Imaging 2020, 52. [Google Scholar] [CrossRef] [PubMed]
- European Society of Radiology (ESR). Medical imaging in personalised medicine: A white paper of the research committee of the European Society of Radiology (ESR). Insights Imaging 2015, 6, 141–155. [Google Scholar] [CrossRef] [PubMed]
- Bruijnen, T.; Van Der Heide, O.; Intven, M.P.W.; Mook, S.; Lagendijk, J.J.W.; Berg, C.A.T.V.D.; Tijssen, R.H.N. Technical Feasibility of Magnetic Resonance Fingerprinting on a 1.5T MRI-linac. 2020. Available online: http://arxiv.org/abs/2007.06209 (accessed on 19 July 2020).
- Lagendijk, J.J.; Raaymakers, B.W.; Raaijmakers, A.J.; Overweg, J.; Brown, K.J.; Kerkhof, E.M.; van der Put, R.W.; Hårdemark, B.; van Vulpen, M.; van der Heide, U.A. MRI/linac integration. Radiother. Oncol. 2008, 86, 25–29. [Google Scholar] [CrossRef] [PubMed]
- Verellen, D.; De Ridder, M.; Linthout, N.; Tournel, K.; Soete, G.; Storme, G. Innovations in image-guided radiotherapy. Nat. Rev. Cancer 2007, 7, 949–960. [Google Scholar] [CrossRef] [PubMed]
- Cruz, G.; Jaubert, O.; Schneider, T.; Botnar, R.M.; Prieto, C. Rigid motion-corrected magnetic resonance fingerprinting. Magn. Reson. Med. 2018, 81, 947–961. [Google Scholar] [CrossRef] [PubMed]
- Yu, Z.; Zhao, T.; Assländer, J.; Lattanzi, R.; Sodickson, D.; Cloos, M. Exploring the sensitivity of magnetic resonance fingerprinting to motion. Magn. Reson. Imaging 2018, 54, 241–248. [Google Scholar] [CrossRef] [PubMed]
- Mehta, B.B.; Ma, D.; Pierre, E.Y.; Jiang, Y.; Coppo, S.; Griswold, M.A. Image reconstruction algorithm for motion insensitive MR Fingerprinting (MRF): MORF. Magn. Reson. Med. 2018, 80, 2485–2500. [Google Scholar] [CrossRef] [PubMed]
- Xu, Z.; Ye, H.; Lyu, M.; He, H.; Zhong, J.; Mei, Y.; Chen, Z.; Wu, E.X.; Chen, W.; Feng, Q.; et al. Rigid motion correction for magnetic resonance fingerprinting with sliding-window reconstruction and image registration. Magn. Reson. Imaging 2019, 57, 303–312. [Google Scholar] [CrossRef] [PubMed]
- Cruz, G.; Schneider, T.; Bruijnen, T.; Gaspar, A.S.; Botnar, R.M.; Prieto, C. Accelerated magnetic resonance fingerprinting using soft-weighted key-hole (MRF-SOHO). PLoS ONE 2018, 13, e0201808. [Google Scholar] [CrossRef]
- Anderson, C.E.; Wang, C.Y.; Gu, Y.; Darrah, R.; Griswold, M.A.; Yu, X.; Flask, C.A. Regularly incremented phase encoding—MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn. Reson. Med. 2017, 79, 2176–2182. [Google Scholar] [CrossRef]
- Cao, X.; Ye, H.; Liao, C.; Li, Q.; He, H.; Zhong, J. Fast 3D brain MR fingerprinting based on multi-axis spiral projection trajectory. Magn. Reson. Med. 2019, 82, 289–301. [Google Scholar] [CrossRef]
- Kurzawski, J.W.; Cencini, M.; Peretti, L.; Gómez, P.A.; Schulte, R.F.; Donatelli, G.; Cosottini, M.; Cecchi, P.; Costagli, M.; Retico, A.; et al. Retrospective rigid motion correction of three-dimensional magnetic resonance fingerprinting of the human brain. Magn. Reson. Med. 2020, 84, 2606–2615. [Google Scholar] [CrossRef] [PubMed]
- Jaubert, O.; Arrieta, C.; Cruz, G.; Bustin, A.; Schneider, T.; Georgiopoulos, G.; Masci, P.; Sing-Long, C.; Botnar, R.M.; Prieto, C. Multi-parametric liver tissue characterization using MR fingerprinting: Simultaneous T1, T2, T2*, and fat fraction mapping. Magn. Reson. Med. 2020, 84, 2625–2635. [Google Scholar] [CrossRef] [PubMed]
- Serrao, E.M.; Kessler, D.A.; Carmo, B.; Beer, L.; Brindle, K.M.; Buonincontri, G.; Gallagher, F.A.; Gilbert, F.J.; Godfrey, E.; Graves, M.J.; et al. Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T. Sci. Rep. 2020, 10, 17563. [Google Scholar] [CrossRef] [PubMed]
- Yang, M.; Ma, D.; Jiang, Y.; Hamilton, J.; Seiberlich, N.; Griswold, M.A.; McGivney, D. Low rank approximation methods for MR fingerprinting with large scale dictionaries. Magn. Reson. Med. 2017, 79, 2392–2400. [Google Scholar] [CrossRef] [PubMed]
- Mazor, G.; Weizman, L.; Tal, A.; Eldar, Y.C. Low-rank magnetic resonance fingerprinting. Med. Phys. 2018, 45, 4066–4084. [Google Scholar] [CrossRef] [PubMed]
- Zhao, B.; Setsompop, K.; Adalsteinsson, E.; Gagoski, B.; Ye, H.; Ma, D.; Jiang, Y.; Grant, P.E.; Griswold, M.A.; Wald, L.L. Improved magnetic resonance fingerprinting reconstruction with low-rank and subspace modeling. Magn. Reson. Med. 2018, 79, 933–942. [Google Scholar] [CrossRef] [PubMed]
- Assländer, J.; Cloos, M.; Knoll, F.; Sodickson, D.K.; Hennig, J.; Lattanzi, R. Low rank alternating direction method of multipliers reconstruction for MR fingerprinting. Magn. Reson. Med. 2018, 79, 83–96. [Google Scholar] [CrossRef] [PubMed]
- Ma, D.; Jiang, Y.; Chen, Y.; McGivney, D.; Mehta, B.; Gulani, V.; Griswold, M. Fast 3D magnetic resonance fingerprinting for a whole-brain coverage. Magn. Reson. Med. 2017, 79, 2190–2197. [Google Scholar] [CrossRef] [PubMed]
- Liao, C.; Bilgic, B.; Manhard, M.K.; Zhao, B.; Cao, X.; Zhong, J.; Wald, L.L.; Setsompop, K. 3D MR fingerprinting with accelerated stack-of-spirals and hybrid sliding-window and GRAPPA reconstruction. NeuroImage 2017, 162, 13–22. [Google Scholar] [CrossRef] [PubMed]
- Oksuz, I.; Cruz, G.; Clough, J.; Bustin, A.; Fuin, N.; Botnar, R.; Prieto, C.; King, A.P.; Schnabel, J.A. Magnetic Resonance Fingerprinting Using Recurrent Neural Networks. In Proceedings of the 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019), Venice, Italy, 8–11 April 2019; pp. 1537–1540. [Google Scholar]
- Cohen, O.; Zhu, B.; Rosen, M.S. MR fingerprinting Deep RecOnstruction NEtwork (DRONE). Magn. Reson. Med. 2018, 80, 885–894. [Google Scholar] [CrossRef] [PubMed]
- O’Connor, J.P.B.; Aboagye, E.; Adams, J.E.; Aerts, H.J.W.L.; Barrington, S.F.; Beer, A.J.; Boellaard, R.; Bohndiek, S.; Brady, M.; Brown, G.; et al. Imaging biomarker roadmap for cancer studies. Nat. Rev. Clin. Oncol. 2017, 14, 169–186. [Google Scholar] [CrossRef] [PubMed]
- GitHub—Imr-Framework/Mrf: An End to End, Vendor Neutral MRF Package. Available online: https://github.com/imr-framework/mrf (accessed on 6 September 2021).
Title | First Author | Journal | Year of Publication | Focused on: Technical/ Clinical/Both | Focused on: Cancer/Non-Cancer/Both |
---|---|---|---|---|---|
Cardiac magnetic resonance fingerprinting: technical developments and initial clinical validation [21] | Gastao Cruz | Current Cardiology Reports | 2019 | both | non-cancer |
Cardiac magnetic resonance fingerprinting: technical overview and initial results [22] | Yuchi Liu | JACC: Cardiovascular Imaging | 2018 | technical | non-cancer |
Cardiac magnetic resonance fingerprinting: trends in technical development and potential clinical applications [23] | Brendan L Eck | Progress in Nuclear Magnetic Resonance Spectroscopy | 2021 | both | non-cancer |
Magnetic resonance fingerprinting Part 1: Potential uses, current challenges, and recommendations [24] | Megan E Poorman | Journal of Magnetic Resonance Imaging | 2019 | both | both |
Magnetic resonance fingerprinting review Part 2: Technique and directions [19] | Debra F McGivney | Journal of Magnetic Resonance Imaging | 2019 | technical | non-cancer |
Magnetic resonance fingerprinting: a technical review [18] | Bhairav B Mehta | Magnetic Resonance in Medicine | 2018 | technical | non-cancer |
Magnetic resonance fingerprinting: an overview [25] | Ananya Panda | Current Opinion in Biomedical Engineering | 2017 | both | both |
Magnetic resonance fingerprinting: from evolution to clinical applications [20] | Jean J L Hsieh | Journal of Medical Radiation Sciences | 2020 | both | non-cancer |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ding, H.; Velasco, C.; Ye, H.; Lindner, T.; Grech-Sollars, M.; O’Callaghan, J.; Hiley, C.; Chouhan, M.D.; Niendorf, T.; Koh, D.-M.; et al. Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer. Cancers 2021, 13, 4742. https://doi.org/10.3390/cancers13194742
Ding H, Velasco C, Ye H, Lindner T, Grech-Sollars M, O’Callaghan J, Hiley C, Chouhan MD, Niendorf T, Koh D-M, et al. Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer. Cancers. 2021; 13(19):4742. https://doi.org/10.3390/cancers13194742
Chicago/Turabian StyleDing, Hao, Carlos Velasco, Huihui Ye, Thomas Lindner, Matthew Grech-Sollars, James O’Callaghan, Crispin Hiley, Manil D. Chouhan, Thoralf Niendorf, Dow-Mu Koh, and et al. 2021. "Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer" Cancers 13, no. 19: 4742. https://doi.org/10.3390/cancers13194742